TRAF Family Member 4 Promotes Cardiac Hypertrophy Through the Activation of the AKT Pathway

TRAF Family Member 4 Promotes Cardiac Hypertrophy Through the Activation of the AKT Pathway

Background Pathological cardiac hypertrophy is a major cause of heart failure morbidity. The complex mechanism of intermolecular interactions underlying the pathogenesis of cardiac hypertrophy has led to a lack of development and application of therapeutic methods. Methods and Results Our study prov...

Full description

Bibliographic Details
Main Authors: Jian Li, Chang‐Quan Wang, Wen‐Chang Xiao, Yun Chen, Jun Tu, Feng Wan, Ke‐Qiong Deng, Huo‐Ping Li
Format: Article
Language:English
Published: Wiley 2023-09-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
AKT pathway
cardiac hypertrophy
heart failure
phenylephrine
primary neonatal rat cardiomyocytes
TRAF4
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.122.028185

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.122.028185

Similar Items